-
Moderna Edges Pfizer in Study of Five Covid Vaccines
FirstWordPharma
November 26, 2021
According to the paper published on the website of the Clinical Microbiology and Infection journal, Moderna's COVID-19 vaccine edged Pfizer/BioNTech's jab in effectiveness...
-
Zydus Cadila likely to launch Covid-19 vaccine ZyCoV-D next month Ref: Business Standard
FirstWordPharma
November 26, 2021
India's fourth COVID-19 vaccine is likely to be available next month as sources say Cadila Healthcare's ZyCoV-D, the world’s first plasmid DNA vaccine, will be launched in December, reported Business Standard.
-
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Drugs
November 26, 2021
Pfizer Inc. and BioNTech SE today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age...
-
COVID Protection Wanes After 2 Doses of Pfizer Vaccine: Study
Drugs
November 26, 2021
Protection can gradually fade after a second dose of the COVID-19 vaccine by Pfizer-BioNTech, which suggests that a booster shot might be necessary, researchers report.
-
Health Canada approves Johnson & Johnson’s single-dose Covid-19 vaccine
Pharmaceutical-Business-Review
November 26, 2021
Health Canada has granted full approval to Janssen Pharmaceutical Companies of Johnson & Johnson’s single-dose Covid-19 vaccine for the disease prevention in people aged 18 years and above.
-
Health Canada approves J&J Covid-19 vaccine for use in adults
Pharmaceutical-Technology
November 26, 2021
Health Canada has granted full approval for Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for active immunisation to prevent infection in adults aged 18 years and older.
-
Novavax seeks interim authorisation for Covid-19 vaccine in Singapore
Pharmaceutical-Technology
November 26, 2021
US-based biotechnology firm Novavax has filed an application seeking interim authorisation from the Singapore Health Sciences Authority (HSA) for its Covid-19 vaccine, NVX-CoV2373, under the Pandemic Special Access Route.
-
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
prnasia
November 25, 2021
GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp...
-
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study
ExpressPharma
November 25, 2021
Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.
-
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older
AmericanPharmaceuticalReview
November 25, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.